Annual Gross Profit
$992.00 K
-$244.80 K-19.79%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual gross profit is $992.00 thousand, with the most recent change of -$244.80 thousand (-19.79%) on December 31, 2023.
- During the last 3 years, CYTH annual gross profit has risen by +$155.00 thousand (+18.52%).
- CYTH annual gross profit is now -30.61% below its all-time high of $1.43 million, reached on December 31, 2021.
Performance
CYTH Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$217.00 K
+$107.30 K+97.81%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly gross profit is $217.00 thousand, with the most recent change of +$107.30 thousand (+97.81%) on September 30, 2024.
- Over the past year, CYTH quarterly gross profit has dropped by -$78.90 thousand (-26.66%).
- CYTH quarterly gross profit is now -61.44% below its all-time high of $562.80 thousand, reached on June 30, 2013.
Performance
CYTH Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$813.20 K
-$239.70 K-22.77%
September 30, 2024
Summary
- As of February 8, 2025, CYTH TTM gross profit is $813.20 thousand, with the most recent change of -$239.70 thousand (-22.77%) on September 30, 2024.
- Over the past year, CYTH TTM gross profit has dropped by -$178.80 thousand (-18.02%).
- CYTH TTM gross profit is now -48.60% below its all-time high of $1.58 million, reached on September 30, 2022.
Performance
CYTH TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
CYTH Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.8% | -26.7% | -18.0% |
| 3 y3 years | +18.5% | -26.7% | -18.0% |
| 5 y5 years | +9.4% | -26.7% | -18.0% |
CYTH Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.6% | at low | -58.0% | +123.3% | -48.6% | at low |
| 5 y | 5-year | -30.6% | +18.5% | -58.0% | +123.3% | -48.6% | at low |
| alltime | all time | -30.6% | +288.4% | -61.4% | +409.4% | -48.6% | +1194.9% |
Cyclo Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $217.00 K(+97.8%) | $813.20 K(-22.8%) |
| Jun 2024 | - | $109.70 K(-42.4%) | $1.05 M(+1.2%) |
| Mar 2024 | - | $190.60 K(-35.6%) | $1.04 M(+4.9%) |
| Dec 2023 | $992.00 K(-19.8%) | $295.90 K(-35.2%) | $992.00 K(+14.4%) |
| Sep 2023 | - | $456.70 K(+369.9%) | $867.10 K(+4.5%) |
| Jun 2023 | - | $97.20 K(-31.6%) | $829.50 K(-30.9%) |
| Mar 2023 | - | $142.20 K(-16.8%) | $1.20 M(-2.9%) |
| Dec 2022 | $1.24 M(-13.5%) | $171.00 K(-59.2%) | $1.24 M(-21.8%) |
| Sep 2022 | - | $419.10 K(-10.5%) | $1.58 M(+2.5%) |
| Jun 2022 | - | $468.20 K(+162.4%) | $1.54 M(+20.2%) |
| Mar 2022 | - | $178.40 K(-65.5%) | $1.28 M(-10.1%) |
| Dec 2021 | $1.43 M(+70.8%) | $516.50 K(+35.5%) | $1.43 M(+37.0%) |
| Sep 2021 | - | $381.20 K(+82.9%) | $1.04 M(+19.5%) |
| Jun 2021 | - | $208.40 K(-35.6%) | $872.90 K(+1.4%) |
| Mar 2021 | - | $323.50 K(+148.7%) | $861.10 K(+2.9%) |
| Dec 2020 | $837.00 K(-10.2%) | $130.10 K(-38.3%) | $836.90 K(-9.2%) |
| Sep 2020 | - | $210.90 K(+7.3%) | $921.50 K(-5.0%) |
| Jun 2020 | - | $196.60 K(-34.3%) | $970.50 K(-5.8%) |
| Mar 2020 | - | $299.30 K(+39.4%) | $1.03 M(+10.6%) |
| Dec 2019 | $931.70 K(+2.8%) | $214.70 K(-17.4%) | $931.70 K(-1.1%) |
| Sep 2019 | - | $259.90 K(+1.2%) | $942.20 K(+5.4%) |
| Jun 2019 | - | $256.80 K(+28.2%) | $893.70 K(-4.1%) |
| Mar 2019 | - | $200.30 K(-11.1%) | $932.30 K(+2.9%) |
| Dec 2018 | $906.50 K(-17.9%) | $225.20 K(+6.5%) | $906.40 K(+8.6%) |
| Sep 2018 | - | $211.40 K(-28.4%) | $834.80 K(-1.2%) |
| Jun 2018 | - | $295.40 K(+69.4%) | $844.90 K(-15.0%) |
| Mar 2018 | - | $174.40 K(+13.5%) | $993.60 K(-10.1%) |
| Dec 2017 | $1.10 M(-15.3%) | $153.60 K(-30.7%) | $1.10 M(-21.3%) |
| Sep 2017 | - | $221.50 K(-50.1%) | $1.40 M(-1.8%) |
| Jun 2017 | - | $444.10 K(+55.4%) | $1.43 M(+8.8%) |
| Mar 2017 | - | $285.70 K(-36.9%) | $1.31 M(+0.8%) |
| Dec 2016 | $1.30 M(+57.9%) | $453.10 K(+83.2%) | $1.30 M(+31.2%) |
| Sep 2016 | - | $247.30 K(-24.6%) | $994.30 K(+4.0%) |
| Jun 2016 | - | $328.20 K(+19.0%) | $956.40 K(+0.6%) |
| Mar 2016 | - | $275.90 K(+93.1%) | $951.10 K(+15.2%) |
| Dec 2015 | $826.00 K(-36.2%) | $142.90 K(-31.8%) | $825.90 K(-17.2%) |
| Sep 2015 | - | $209.40 K(-35.2%) | $997.60 K(-11.7%) |
| Jun 2015 | - | $322.90 K(+114.3%) | $1.13 M(+18.0%) |
| Mar 2015 | - | $150.70 K(-52.1%) | $957.00 K(-23.2%) |
| Dec 2014 | $1.29 M(+2.2%) | $314.60 K(-7.8%) | $1.25 M(+10.3%) |
| Sep 2014 | - | $341.10 K(+126.5%) | $1.13 M(+21.9%) |
| Jun 2014 | - | $150.60 K(-65.8%) | $927.30 K(-30.8%) |
| Mar 2014 | - | $439.90 K(+121.5%) | $1.34 M(+5.7%) |
| Dec 2013 | $1.27 M(+40.0%) | $198.60 K(+43.7%) | $1.27 M(-8.3%) |
| Sep 2013 | - | $138.20 K(-75.4%) | $1.38 M(+0.3%) |
| Jun 2013 | - | $562.80 K(+53.1%) | $1.38 M(+46.5%) |
| Mar 2013 | - | $367.70 K(+17.2%) | $940.70 K(+3.9%) |
| Dec 2012 | $905.30 K | $313.80 K(+133.8%) | $905.40 K(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $134.20 K(+7.4%) | $758.20 K(-7.4%) |
| Jun 2012 | - | $125.00 K(-62.4%) | $818.50 K(-7.4%) |
| Mar 2012 | - | $332.40 K(+99.5%) | $883.90 K(+16.6%) |
| Dec 2011 | $758.10 K(+10.2%) | $166.60 K(-14.3%) | $758.20 K(-8.2%) |
| Sep 2011 | - | $194.50 K(+2.2%) | $825.80 K(+3.9%) |
| Jun 2011 | - | $190.40 K(-7.9%) | $794.70 K(+7.0%) |
| Mar 2011 | - | $206.70 K(-11.7%) | $742.70 K(+9.1%) |
| Dec 2010 | $687.70 K(+34.1%) | $234.20 K(+43.3%) | $680.50 K(+19.1%) |
| Sep 2010 | - | $163.40 K(+18.1%) | $571.20 K(-2.2%) |
| Jun 2010 | - | $138.40 K(-4.2%) | $583.90 K(+5.5%) |
| Mar 2010 | - | $144.50 K(+15.7%) | $553.20 K(+7.8%) |
| Dec 2009 | $513.00 K(+29.7%) | $124.90 K(-29.1%) | $513.10 K(+3.9%) |
| Sep 2009 | - | $176.10 K(+63.5%) | $493.90 K(+8.1%) |
| Jun 2009 | - | $107.70 K(+3.2%) | $456.80 K(+2.4%) |
| Mar 2009 | - | $104.40 K(-1.2%) | $446.30 K(+14.5%) |
| Dec 2008 | $395.60 K(-37.5%) | $105.70 K(-24.0%) | $389.80 K(-7.1%) |
| Sep 2008 | - | $139.00 K(+43.0%) | $419.50 K(-9.1%) |
| Jun 2008 | - | $97.20 K(+102.9%) | $461.60 K(-13.2%) |
| Mar 2008 | - | $47.90 K(-64.6%) | $531.60 K(-16.0%) |
| Dec 2007 | $632.80 K(+51.7%) | $135.40 K(-25.2%) | $632.80 K(+2.4%) |
| Sep 2007 | - | $181.10 K(+8.3%) | $618.00 K(+19.5%) |
| Jun 2007 | - | $167.20 K(+12.1%) | $517.30 K(+17.7%) |
| Mar 2007 | - | $149.10 K(+23.6%) | $439.60 K(+5.4%) |
| Dec 2006 | $417.10 K(+7.6%) | $120.60 K(+50.0%) | $417.10 K(+17.2%) |
| Sep 2006 | - | $80.40 K(-10.2%) | $356.00 K(-6.1%) |
| Jun 2006 | - | $89.50 K(-29.3%) | $379.10 K(-8.3%) |
| Mar 2006 | - | $126.60 K(+112.8%) | $413.30 K(+6.6%) |
| Dec 2005 | $387.70 K(+0.5%) | $59.50 K(-42.5%) | $387.80 K(-1.1%) |
| Sep 2005 | - | $103.50 K(-16.3%) | $392.20 K(-0.2%) |
| Jun 2005 | - | $123.70 K(+22.4%) | $392.80 K(+4.2%) |
| Mar 2005 | - | $101.10 K(+58.2%) | $377.10 K(-2.3%) |
| Dec 2004 | $385.90 K(+10.5%) | $63.90 K(-38.6%) | $385.80 K(-19.5%) |
| Sep 2004 | - | $104.10 K(-3.6%) | $479.40 K(+6.1%) |
| Jun 2004 | - | $108.00 K(-1.6%) | $452.00 K(+8.6%) |
| Mar 2004 | - | $109.80 K(-30.3%) | $416.30 K(+19.2%) |
| Dec 2003 | $349.10 K(-20.3%) | $157.50 K(+105.3%) | $349.10 K(+47.3%) |
| Sep 2003 | - | $76.70 K(+6.1%) | $237.00 K(-17.4%) |
| Jun 2003 | - | $72.30 K(+69.7%) | $286.90 K(-10.3%) |
| Mar 2003 | - | $42.60 K(-6.2%) | $319.80 K(-27.0%) |
| Dec 2002 | $437.90 K(+71.5%) | $45.40 K(-64.1%) | $438.00 K(+0.3%) |
| Sep 2002 | - | $126.60 K(+20.3%) | $436.70 K(+19.2%) |
| Jun 2002 | - | $105.20 K(-34.6%) | $366.50 K(+7.8%) |
| Mar 2002 | - | $160.80 K(+264.6%) | $339.90 K(+33.1%) |
| Dec 2001 | $255.40 K(-11.6%) | $44.10 K(-21.8%) | $255.40 K(0.0%) |
| Sep 2001 | - | $56.40 K(-28.2%) | $255.40 K(-2.4%) |
| Jun 2001 | - | $78.60 K(+3.0%) | $261.80 K(+42.9%) |
| Mar 2001 | - | $76.30 K(+73.0%) | $183.20 K(+71.4%) |
| Dec 2000 | $289.00 K | $44.10 K(-29.8%) | $106.90 K(+70.2%) |
| Sep 2000 | - | $62.80 K | $62.80 K |
FAQ
- What is Cyclo Therapeutics annual gross profit?
- What is the all time high annual gross profit for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual gross profit year-on-year change?
- What is Cyclo Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly gross profit year-on-year change?
- What is Cyclo Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Cyclo Therapeutics?
- What is Cyclo Therapeutics TTM gross profit year-on-year change?
What is Cyclo Therapeutics annual gross profit?
The current annual gross profit of CYTH is $992.00 K
What is the all time high annual gross profit for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual gross profit is $1.43 M
What is Cyclo Therapeutics annual gross profit year-on-year change?
Over the past year, CYTH annual gross profit has changed by -$244.80 K (-19.79%)
What is Cyclo Therapeutics quarterly gross profit?
The current quarterly gross profit of CYTH is $217.00 K
What is the all time high quarterly gross profit for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly gross profit is $562.80 K
What is Cyclo Therapeutics quarterly gross profit year-on-year change?
Over the past year, CYTH quarterly gross profit has changed by -$78.90 K (-26.66%)
What is Cyclo Therapeutics TTM gross profit?
The current TTM gross profit of CYTH is $813.20 K
What is the all time high TTM gross profit for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM gross profit is $1.58 M
What is Cyclo Therapeutics TTM gross profit year-on-year change?
Over the past year, CYTH TTM gross profit has changed by -$178.80 K (-18.02%)